CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility ConferenceBusiness Wire • 04/25/23
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung TransplantationBusiness Wire • 04/19/23
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant CommunityBusiness Wire • 04/06/23
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human TransplantationBusiness Wire • 04/05/23
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant AssociationBusiness Wire • 03/23/23
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNABusiness Wire • 03/11/23
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx's AlloSure Kidney for Organ Transplant SurveillanceBusiness Wire • 03/07/23
CareDx To Participate in the Raymond James & Associates' 44th Annual Institutional Investors ConferenceBusiness Wire • 03/06/23
CareDx Key Supporter of the National Kidney Foundation's Annual Kidney Patient SummitBusiness Wire • 03/01/23
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation MeetingBusiness Wire • 02/22/23
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem MeetingsBusiness Wire • 02/16/23
JACC Publication Guides Use of CareDx's HeartCare Transplant Rejection Surveillance in Clinical PracticeBusiness Wire • 01/26/23
CareDx Fosters Transplant Innovation as Distinguished Founder's Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter SymposiumBusiness Wire • 01/11/23
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022Business Wire • 01/09/23
New ISHLT Guidelines Support Use of CareDx's HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant PatientsBusiness Wire • 12/21/22